Wire Stories
Solasia Announces Launch of Darvias� in Japan
TOKYO–(BUSINESS WIRE)–Solasia Pharma K.K. (TOKYO:4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter �Solasia�) officially announced today that an organoarsenic drug...